Sascha Dammeier
University of Tübingen
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sascha Dammeier.
Diabetes Care | 2013
Rainer Lehmann; Holger Franken; Sascha Dammeier; Lars Rosenbaum; Konstantinos Kantartzis; Andreas Peter; Andreas Zell; Patrick Adam; Jia Li; Guowang Xu; Alfred Königsrainer; Jürgen Machann; Fritz Schick; Martin Hrabé de Angelis; Matthias Schwab; Harald Staiger; Erwin Schleicher; Amalia Gastaldelli; Andreas Fritsche; Hans-Ulrich Häring; Norbert Stefan
OBJECTIVE Nonalcoholic fatty liver (NAFL) is thought to contribute to insulin resistance and its metabolic complications. However, some individuals with NAFL remain insulin sensitive. Mechanisms involved in the susceptibility to develop insulin resistance in humans with NAFL are largely unknown. We investigated circulating markers and mechanisms of a metabolically benign and malignant NAFL by applying a metabolomic approach. RESEARCH DESIGN AND METHODS A total of 265 metabolites were analyzed before and after a 9-month lifestyle intervention in plasma from 20 insulin-sensitive and 20 insulin-resistant subjects with NAFL. The relevant plasma metabolites were then tested for relationships with insulin sensitivity in 17 subjects without NAFL and in plasma from 29 subjects with liver tissue samples. RESULTS The best separation of the insulin-sensitive from the insulin-resistant NAFL group was achieved by a metabolite pattern including the branched-chain amino acids leucine and isoleucine, ornithine, the acylcarnitines C3:0-, C16:0-, and C18:0-carnitine, and lysophosphatidylcholine (lyso-PC) C16:0 (area under the ROC curve, 0.77 [P = 0.00023] at baseline and 0.80 [P = 0.000019] at follow-up). Among the individual metabolites, predominantly higher levels of lyso-PC C16:0, both at baseline (P = 0.0039) and at follow-up (P = 0.001), were found in the insulin-sensitive compared with the insulin-resistant subjects. In the non-NAFL groups, no differences in lyso-PC C16:0 levels were found between the insulin-sensitive and insulin-resistant subjects, and these relationships were replicated in plasma from subjects with liver tissue samples. CONCLUSIONS From a plasma metabolomic pattern, particularly lyso-PCs are able to separate metabolically benign from malignant NAFL in humans and may highlight important pathways in the pathogenesis of fatty liver–induced insulin resistance.
Journal of Immunology | 2016
Gábor Oroszlán; Elod Kortvely; Dávid Szakács; Andrea Kocsis; Sascha Dammeier; Anne Zeck; Marius Ueffing; Péter Závodszky; Gábor Pál; Péter Gál; József Dobó
It had been thought that complement factor D (FD) is activated at the site of synthesis, and only FD lacking a propeptide is present in blood. The serum of mannose-binding lectin–associated serine protease (MASP)-1/3(−/−) mice contains pro-FD and has markedly reduced alternative pathway activity. It was suggested that MASP-1 and MASP-3 directly activate pro-FD; however, other experiments contradicted this view. We decided to clarify the involvement of MASPs in pro-FD activation in normal, as opposed to deficient, human plasma and serum. Human pro-FD containing an APPRGR propeptide was produced in insect cells. We measured its activation kinetics using purified active MASP-1, MASP-2, MASP-3, as well as thrombin. We found all these enzymes to be efficient activators, whereas MASP proenzymes lacked such activity. Pro-FD cleavage in serum or plasma was quantified by a novel assay using fluorescently labeled pro-FD. Labeled pro-FD was processed with t1/2s of ∼3 and 5 h in serum and plasma, respectively, showing that proteolytic activity capable of activating pro-FD exists in blood even in the absence of active coagulation enzymes. Our previously developed selective MASP-1 and MASP-2 inhibitors did not reduce pro-FD activation at reasonable concentration. In contrast, at very high concentration, the MASP-2 inhibitor, which is also a poor MASP-3 inhibitor, slowed down the activation. When recombinant MASPs were added to plasma, only MASP-3 could reduce the half-life of pro-FD. Combining our quantitative data, MASP-1 and MASP-2 can be ruled out as direct pro-FD activators in resting blood; however, active MASP-3 is a very likely physiological activator.
Survey of Ophthalmology | 2018
Eveline Kersten; Constantin C. Paun; Rosa L. Schellevis; Carel B. Hoyng; Cécile Delcourt; Imre Lengyel; Tunde Peto; Marius Ueffing; Caroline C. W. Klaver; Sascha Dammeier; Anneke I. den Hollander; Eiko K. de Jong
Biomarkers can help unravel mechanisms of disease and identify new targets for therapy. They can also be useful in clinical practice for monitoring disease progression, evaluation of treatment efficacy, and risk assessment in multifactorial diseases, such as age-related macular degeneration (AMD). AMD is a highly prevalent progressive retinal disorder for which multiple genetic and environmental risk factors have been described, but the exact etiology is not yet fully understood. Many compounds have been evaluated for their association with AMD. We performed an extensive literature review of all compounds measured in serum, plasma, vitreous, aqueous humor, and urine of AMD patients. Over 3600 articles were screened, resulting in more than 100 different compounds analyzed in AMD studies, involved in neovascularization, immunity, lipid metabolism, extracellular matrix, oxidative stress, diet, hormones, and comorbidities (such as kidney disease). For each compound, we provide a short description of its function and discuss the results of the studies in relation to its usefulness as AMD biomarker. In addition, biomarkers identified by hypothesis-free techniques, including metabolomics, proteomics, and epigenomics, are covered. In summary, compounds belonging to the oxidative stress pathway, the complement system, and lipid metabolism are the most promising biomarker candidates for AMD. We hope that this comprehensive survey of the literature on systemic and ocular fluid compounds as potential biomarkers in AMD will provide a stepping stone for future research and possible implementation in clinical practice.
Journal of Proteome Research | 2016
Sascha Dammeier; Sven Nahnsen; Johannes Veit; Frank Wehner; Marius Ueffing; Oliver Kohlbacher
Standard forensic procedures to examine bullets after an exchange of fire include a mechanical or ballistic reconstruction of the event. While this is routine to identify which projectile hit a subject by DNA analysis of biological material on the surface of the projectile, it is rather difficult to determine which projectile caused the lethal injury--often the crucial point with regard to legal proceedings. With respect to fundamental law it is the duty of the public authority to make every endeavor to solve every homicide case. To improve forensic examinations, we present a forensic proteomic method to investigate biological material from a projectiles surface and determine the tissues traversed by it. To obtain a range of relevant samples, different major bovine organs were penetrated with projectiles experimentally. After tryptic on-surface digestion, mass-spectrometry-based proteome analysis, and statistical data analysis, we were able to achieve a cross-validated organ classification accuracy of >99%. Different types of anticipated external variables exhibited no prominent influence on the findings. In addition, shooting experiments were performed to validate the results. Finally, we show that these concepts could be applied to a real case of murder to substantially improve the forensic reconstruction.
Progress in Retinal and Eye Research | 2018
Elisabeth M. van Leeuwen; Eszter Emri; Bénédicte M. J. Merle; Johanna Maria Colijn; Eveline Kersten; Audrey Cougnard-Grégoire; Sascha Dammeier; Magda A. Meester-Smoor; Frances M. Pool; Eiko K. de Jong; Cécile Delcourt; Eduardo Rodrigez-Bocanegra; Marc Biarnés; Philip J. Luthert; Marius Ueffing; Caroline C. W. Klaver; Everson Nogoceke; Anneke I. den Hollander; Imre Lengyel
&NA; There is an urgency to find new treatment strategies that could prevent or delay the onset or progression of AMD. Different classes of lipids and lipoproteins metabolism genes have been associated with AMD in a multiple ways, but despite the ever‐increasing knowledge base, we still do not understand fully how circulating lipids or local lipid metabolism contribute to AMD. It is essential to clarify whether dietary lipids, systemic or local lipoprotein metabolismtrafficking of lipids in the retina should be targeted in the disease. In this article, we critically evaluate what has been reported in the literature and identify new directions needed to bring about a significant advance in our understanding of the role for lipids in AMD. This may help to develop potential new treatment strategies through targeting the lipid homeostasis. HighlightsHigh dietary intake of omega‐3 is consistently associated with decreased risk of AMD.HDL‐C levels are elevated and triglycerides are decreased in AMD patients.Composition and activity of HDL particles might be relevant for AMD.Genes involved in cholesterol transport associate with both AMD and lipid levels.AMD pathogenesis may be related to circulating lipids, local lipid transport, or both.
Ophthalmology | 2018
Bénédicte M. J. Merle; Johanna M. Colijn; Audrey Cougnard-Grégoire; Alexandra P.M. de Koning-Backus; Marie-Noëlle Delyfer; Jessica C. Kiefte-de Jong; Magda Meester-Smoor; Catherine Féart; Timo Verzijden; Cécilia Samieri; Oscar H. Franco; Jean-François Korobelnik; Caroline C. W. Klaver; Cécile Delcourt; Soufiane Ajana; Blanca Arango-Gonzalez; Angela Armento; Verena Arndt; Vaibhav Bhatia; Shomi S. Bhattacharya; Marc Biarnés; Anna Borrell; Sebastian Bühren; Sofia M. Calado; Sascha Dammeier; Eiko K. de Jong; Berta De la Cerda; Anneke I. den Hollander; Francisco J. Diaz-Corrales; Sigrid Diether
PURPOSEnTo investigate associations of adherence to the Mediterranean diet (MeDi) with incidence of advanced age-related macular degeneration (AMD; the symptomatic form of AMD) in 2 European population-based prospective cohorts.nnnDESIGNnProspective cohort study of the Rotterdam Study I (RS-I) and the Antioxydants, Lipides Essentiels, Nutrition et Maladies Oculaires (Alienor) Study populations.nnnPARTICIPANTSnFour thousand four hundred forty-six participants 55 years of age or older from the RS-I (The Netherlands) and 550 French adults 73 years of age or older from the Alienor Study with complete ophthalmologic and dietary data were included in the present study.nnnMETHODSnExaminations were performed approximately every 5 years over a 21-year period (1990-2011) in RS-I and every 2 years over a 4-year period (2006-2012) in the Alienor Study. Adherence to the MeDi was evaluated using a 9-component score based on intake of vegetables, fruits, legumes, cereals, fish, meat, dairy products, alcohol, and the monounsaturated-to-saturated fatty acids ratio. Associations of incidence of AMD with MeDi were estimated using multivariate Cox proportional hazard models.nnnMAIN OUTCOMES MEASURESnIncidence of advanced AMD based on retinal fundus photographs.nnnRESULTSnAmong the 4996 included participants, 155 demonstrated advanced incident AMD (117 from the RS-I and 38 from the Alienor Study). The mean follow-up time was 9.9 years (range, 0.6-21.7 years) in the RS-I and 4.1 years (range, 2.5-5.0 years) in the Alienor Study. Pooling data for both the RS-I and Alienor Study, participants with a high (range, 6-9) MeDi score showed a significantly reduced risk for incident advanced AMD compared with participants with a low (range, 0-3) MeDi score in the fully adjusted Cox model (hazard ratio, 0.59; 95% confidence interval, 0.37-0.95; Pxa0= 0.04 for trend).nnnCONCLUSIONSnPooling data from the RS-I and Alienor Study, higher adherence to the MeDi was associated with a 41% reduced risk of incident advanced AMD. These findings support the role of a diet rich in healthfulxa0nutrient-rich foods such as fruits, vegetables, legumes, and fish in the prevention of AMD.
Investigative Ophthalmology & Visual Science | 2013
Florian Gekeler; Helmut G. Sachs; Veronique Kitiratschky; Katarina Stingl; Udo Greppmaier; Eberhart Zrenner; Karl Ulrich Bartz-Schmidt; Marius Ueffing; Sascha Dammeier
Archive | 2017
Sascha Dammeier; Eloed Koertvély; Marius Ueffing
Investigative Ophthalmology & Visual Science | 2017
Elod Kortvely; Eszter Emri; Sascha Dammeier; Marius Ueffing; Imre Lengyel
Investigative Ophthalmology & Visual Science | 2017
Sven Schnichels; Jan Willem de Vries; Agnieszka Gruszka; Karl Ulrich Bartz-Schmidt; Sascha Dammeier; Andreas Herrmann; Martin S. Spitzer; Jose Hurst